Tags

Type your tag names separated by a space and hit enter

The Effects of Hemocoagulase on Coagulation Factors in an Elderly Patient with Upper Gastrointestinal Hemorrhage: A Case Report.
Curr Drug Saf. 2019; 14(3):230-232.CD

Abstract

BACKGROUND

Hemocoagulase agkistrodon has been widely used for visceral bleeding, however, its adverse reaction has not been fully recognized.

CASE REPORT

A 65-year-old female with upper gastrointestinal hemorrhage occurred severe coagulation disorder during her hospitalization. Transfusion of blood products can not improve coagulation function. Coagulation parameters returned to normal two days after discontinuation of hemocoagulase agkistrodon.

CONCLUSION

So intravenous administration of hemocoagulase should be cautiously used for the treatment of gastrointestinal bleeding.

Authors+Show Affiliations

Department of General Practice, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.

Pub Type(s)

Case Reports

Language

eng

PubMed ID

31124425

Citation

Zhang, Haiyan. "The Effects of Hemocoagulase On Coagulation Factors in an Elderly Patient With Upper Gastrointestinal Hemorrhage: a Case Report." Current Drug Safety, vol. 14, no. 3, 2019, pp. 230-232.
Zhang H. The Effects of Hemocoagulase on Coagulation Factors in an Elderly Patient with Upper Gastrointestinal Hemorrhage: A Case Report. Curr Drug Saf. 2019;14(3):230-232.
Zhang, H. (2019). The Effects of Hemocoagulase on Coagulation Factors in an Elderly Patient with Upper Gastrointestinal Hemorrhage: A Case Report. Current Drug Safety, 14(3), 230-232. https://doi.org/10.2174/1574886314666190524093711
Zhang H. The Effects of Hemocoagulase On Coagulation Factors in an Elderly Patient With Upper Gastrointestinal Hemorrhage: a Case Report. Curr Drug Saf. 2019;14(3):230-232. PubMed PMID: 31124425.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The Effects of Hemocoagulase on Coagulation Factors in an Elderly Patient with Upper Gastrointestinal Hemorrhage: A Case Report. A1 - Zhang,Haiyan, PY - 2019/03/31/received PY - 2019/04/28/revised PY - 2019/05/01/accepted PY - 2019/5/28/pubmed PY - 2020/2/13/medline PY - 2019/5/25/entrez KW - Coagulation disorder KW - Hemocoagulase agkistrodon KW - enzymes KW - fibrinopeptide KW - gastrointestinal hemorrhage KW - hypofibrinogenemia. SP - 230 EP - 232 JF - Current drug safety JO - Curr Drug Saf VL - 14 IS - 3 N2 - BACKGROUND: Hemocoagulase agkistrodon has been widely used for visceral bleeding, however, its adverse reaction has not been fully recognized. CASE REPORT: A 65-year-old female with upper gastrointestinal hemorrhage occurred severe coagulation disorder during her hospitalization. Transfusion of blood products can not improve coagulation function. Coagulation parameters returned to normal two days after discontinuation of hemocoagulase agkistrodon. CONCLUSION: So intravenous administration of hemocoagulase should be cautiously used for the treatment of gastrointestinal bleeding. SN - 2212-3911 UR - https://www.unboundmedicine.com/medline/citation/31124425/The_Effects_of_Hemocoagulase_on_Coagulation_Factors_in_an_Elderly_Patient_with_Upper_Gastrointestinal_Hemorrhage:_A_Case_Report_ L2 - http://www.eurekaselect.com/172263/article DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.